AXSOME THERAPEUTICS, INC. (AXSM) Return on equity 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-207.5%FY2025 · since FY2022: -170.8% → -207.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -207.5% | +296.3 pp |
| FY2024 | -503.8% | -378.5 pp |
| FY2023 | -125.3% | +45.5 pp |
| FY2022 | -170.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating marginAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →